このアイテムのアクセス数: 831
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
69_1_13.pdf | 781.51 kB | Adobe PDF | 見る/開く |
タイトル: | 後腹膜原発悪性リンパ腫の1例 |
その他のタイトル: | Retroperitoneal Malignant Lymphoma: A Case Report |
著者: | 川村, 竜也 ![]() 守口, 万里子 ![]() 小成, 晋 ![]() 村井, 一範 ![]() 加藤, 陽一郎 ![]() 小原, 航 ![]() |
著者名の別形: | KAWAMURA, Tatsuya MORIGUCHI, Mariko KONARI, Susumu MURAI, Kazunori KATO, Yoichiro OBARA, Wataru |
キーワード: | Retroperitoneum Malignant lymphoma US-guided biopsy R-THP-COP therapy |
発行日: | 31-Jan-2023 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 69 |
号: | 1 |
開始ページ: | 13 |
終了ページ: | 17 |
抄録: | A male patient in his 70s was referred to our hospital with the chief complaint of anorexia. Abdominal computed tomography (CT) showed a 20 cm large homogeneous mass in the retroperitoneum, and contrast-enhanced CT revealed uniform staining throughout the inside of the mass. Soluble interleukin-2 receptor and lactate dehydrogenase tumor markers were elevated. Hence, malignant lymphoma was suspected, and ultrasonography-guided biopsy was performed. Histopathological findings showed large lymphocytes with poorly differentiated cytoplasmic nucleoli and positivity for CD20 and CD79a via immunohistochemical analysis, which was consistent with diffuse large B-cell lymphoma. The patient received R-THP-COP therapy which consisted of rituximab, pirarubicin, cyclophosphamide, vincristine and prednisolone. After four chemotherapy courses, a partial response according to the the response evaluation criteria in solid tumors was obtained. The patient was discharged with no signs of recurrence. |
著作権等: | 許諾条件により本文は2024-02-01に公開 |
DOI: | 10.14989/ActaUrolJap_69_1_13 |
URI: | http://hdl.handle.net/2433/279051 |
PubMed ID: | 36727456 |
出現コレクション: | Vol.69 No.1 |

このリポジトリに保管されているアイテムはすべて著作権により保護されています。